Clozapine
Active substance: clozapine
TABLET, ORALLY DISINTEGRATING · CLOZAPINE 25 mg/1
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- CLOZAPINE · 25 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 18 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-38b1-765e-b24a-53d6086927bf,01a120c3-41cf-70f2-940a-74bd0924a552,01a120c3-4362-71e4-ae59-1414dd1642fb,01a120c3-69cb-74de-970d-84a256bc7a0b,01a120c3-71ee-78be-bb3a-53a34682751a;count=14 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2cd7-7da1-ac47-e61ee2920464,01a1208c-6d45-7d34-8910-19f42511fab8,01a1208c-810c-7283-bf5e-3daabecbf40b,01a1208c-9b0a-723a-840a-bd0faa5b29f5,01a1208c-b394-7d50-bf09-4cbebe488c21;count=48 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0378-3813
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 0378-3813 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0378-3813 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0378-3813 · Verified 2026-10-09 · open in source